Form 8-K - Current report:
SEC Accession No. 0001728117-26-000022
Filing Date
2026-04-09
Accepted
2026-04-09 16:01:13
Documents
11
Period of Report
2026-04-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K goss-20260408.htm   iXBRL 8-K 30561
  Complete submission text file 0001728117-26-000022.txt   144992

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20260408.xsd EX-101.SCH 1794
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20260408_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20260408_pre.xml EX-101.PRE 12516
14 EXTRACTED XBRL INSTANCE DOCUMENT goss-20260408_htm.xml XML 2724
Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 684-1300
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 26851519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)